These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 1269974)
1. Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance. Trepo CG; Robert D; Motin J; Trepo D; Sepetjian M; Prince AM Gut; 1976 Jan; 17(1):10-13. PubMed ID: 1269974 [TBL] [Abstract][Full Text] [Related]
2. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment]. Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739 [TBL] [Abstract][Full Text] [Related]
3. Presence of Hepatitis B Surface Antibody in Addition to Hepatitis B Core Antibody Confers Protection Against Hepatitis B Virus Infection in Hepatitis B Surface Antigen-negative Patients Undergoing Kidney Transplantation. Jeon JW; Kim SM; Cho H; Baek CH; Kim H; Shin S; Kim YH; Han DJ; Kim SB Transplantation; 2018 Oct; 102(10):1717-1723. PubMed ID: 29621059 [TBL] [Abstract][Full Text] [Related]
4. Etiology of fulminant viral hepatitis in Greece. Papaevangelou G; Tassopoulos N; Roumeliotou-Karayannis A; Richardson C Hepatology; 1984; 4(3):369-72. PubMed ID: 6327484 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitis. Pastore G; Dentico P; Angarano G; Zanetti AR; Ferroni P; Frappampina V; Schiraldi O; Roggendorf M; Frösner G J Med Virol; 1981; 7(2):97-103. PubMed ID: 6167671 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to hepatitis B surface and core antigens in haemophiliacs and their contacts among hospital personnel. Hansson BG Scand J Infect Dis; 1977; 9(3):167-9. PubMed ID: 905782 [TBL] [Abstract][Full Text] [Related]
7. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection. Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis and hepatitis B-antigen in Greenland. II: Occurrence and interrelation of hepatitis B associated surface, core, and "e" antigen-antibody systems in a highly endemic area. Skinhoj P Am J Epidemiol; 1977 Feb; 105(2):99-106. PubMed ID: 835567 [TBL] [Abstract][Full Text] [Related]
9. Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients. Boyd A; Canini L; Gozlan J; Lascoux-Combe C; Miailhes P; Fonquernie L; Girard PM; Lacombe K J Clin Virol; 2017 Oct; 95():55-60. PubMed ID: 28869890 [TBL] [Abstract][Full Text] [Related]
10. [Viral markers of hepatitis A and B: main characteristics and clinical significance]. Lyra LG Arq Gastroenterol; 1983; 20(3):117-22. PubMed ID: 6329145 [TBL] [Abstract][Full Text] [Related]
11. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination. Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197 [TBL] [Abstract][Full Text] [Related]
12. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088 [TBL] [Abstract][Full Text] [Related]
13. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults. Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363 [TBL] [Abstract][Full Text] [Related]
14. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S; Nakashima Y; Kojiro M; Tabor E J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475 [TBL] [Abstract][Full Text] [Related]
15. Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma. Matsue K; Kimura S; Takanashi Y; Iwama K; Fujiwara H; Yamakura M; Takeuchi M Cancer; 2010 Oct; 116(20):4769-76. PubMed ID: 20597091 [TBL] [Abstract][Full Text] [Related]
16. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection. Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669 [TBL] [Abstract][Full Text] [Related]
17. Serologic markers of hepatitis A and B in chronic active hepatitis. Lindberg J; Frösner G; Hansson BG; Hermodsson S; Iwarson S Scand J Gastroenterol; 1978; 13(5):525-7. PubMed ID: 212821 [TBL] [Abstract][Full Text] [Related]
18. Determination of antibody to hepatitis B core antigen by radioimmunoassay in chronic liver disease. Mizuno M; Yamada G; Sakamoto Y; Yumoto Y; Nagashima H Acta Med Okayama; 1980 Jun; 34(3):155-60. PubMed ID: 6251699 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania. Mueller A; Stoetter L; Kalluvya S; Stich A; Majinge C; Weissbrich B; Kasang C BMC Infect Dis; 2015 Sep; 15():386. PubMed ID: 26399765 [TBL] [Abstract][Full Text] [Related]
20. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]